|
|
|
|
Dr Janet Englund
Dr Englund is Professor of Pediatric Infectious Diseases at University of Washington/Seattle Children's Hospital, and serves as Clinical Associate, Fred Hutchinson Cancer Research Center. She is board certified in Pediatrics and Pediatric Infectious Diseases, and has conducted research on the prevention and treatment of respiratory virus infections in neonates, children and immunocompromised adults. Her research includes studies of diverse vaccines and the characterization of novel respiratory viral diseases. Since 2002, she has directed Pediatric Transplant Infectious Diseases at Seattle Children's Hospital/Fred Hutchinson Cancer Research Center. She was involved in the epidemiology and vaccine evaluation of pandemic influenza A/H1N1 and antiviral resistance. Dr. Englund has a special interest in vaccine-preventable diseases, maternal immunization, and viral respiratory diseases. She is the principal investigator for Seattle in the New Vaccine Surveillance Network, sponsored by the Centers for Disease Control. She served on the Advisory Committee in Immunization Practices (ACIP) from 2007-2011, where she was chair, HPV Working Group, and active in the Influenza Working Group. She is President of the Pediatric Infectious Disease Society, and a member of the ACIP influenza working group, the influenza working group of the Infectious Diseases Society of America , and the SAGE Working Group on Influenza of the WHO.
______________________________________________________________________________________________________ |
|
Dr David Scheilele
Dr Scheifele is Director of the Vaccine Evaluation Center at BC Children's Hospital and Professor of Pediatrics at the University of British Columbia in Vancouver, Canada. He is a specialist in pediatric infectious diseases and vaccinology. He has an extensive program of clinical research involving vaccine clinical trials, immunization program support, vaccine safety and vaccine-preventable disease surveillance. He is the founding chair of the Canadian Association for Immunization Research & Evaluation (CAIRE), a unique collaboration of over 100 Canadian vaccine experts and researchers. He was a co-founder of the IMPACT pediatric surveillance network in 1990 and remains actively involved. He is a co-Principal Investigator of the Influenza Research Network funded by the Public Health Agency of Canada and the Canadian Institutes of Health Research, serving as leader of the Rapid Trials section. Dr. Scheifele has published over 200 peer-reviewed papers and editorials. He was recently presented with the Ross Award by the Canadian Paediatric Society for distinguished career achievement.
__________________________________________________________________________________________
|
|
Dr Jeffrey Hanna
Jeffrey is a Public Health Physician who was the Medical Director, Communicable Disease Control, Tropical Public Health Unit, Queensland Health, for nearly 20 years (1992-2011). His duties then included the surveillance, prevention and control of communicable diseases of public health importance (other than tuberculosis and the sexually transmitted infections) in north Queensland. He has had a long interest in immunisation and the vaccine-preventable diseases; he is a past-member of the Australian Technical Advisory Group on Immunisation. However, his work in north Queensland required him to also learn a lot about flaviviruses (e.g. dengue and Japanese encephalitis), tropical diseases (e.g. melioidosis and malaria) and several other somewhat exotic infections that remain a concern in north Queensland (e.g. bat lyssavirus and leptospirosis). In 2006 he was awarded the Order of Australia for 'service to medicine in the fields of public health and epidemiology, particularly through contributions in the area of communicable disease prevention and control'. He recently commenced a part-time academic position with the School of Public Health, Tropical Medicine & Rehabilitation Sciences, James Cook University. His will endeavour to impart some of his interest and enthusiasm for communicable disease control to students undertaking the Master of Public Health & Tropical Medicine degree at the university.
_________________________________________________________________________________________
|
|
Dr Christine Selvey
Christine is currently the Senior Director, Communicable Diseases Branch of Queensland Health. She is the Communicable Diseases Network Australia (CDNA) representative on the Australian Technical Advisory Group on Immunisation (ATAGI).Christine was the Head of Immunisation in the Northern Territory (NT) Department of Health's Centre for Disease Control from 1999 until 2007, apart from a 12 month period when she had responsibility for the immunisation program in Victoria. During this time, she was a member of the National Immunisation Committee (NIC) and for 12 months was the NIC member on ATAGI. She has been a member of ATAGI working parties and has provided input into the development of the Australian Immunisation Handbook. During Christine's time in the NT, several new vaccines, including pneumococcal conjugate, meningococcal, rotavirus and hepatitis A were added to the immunisation schedule creating significant challenges for vaccination of children, particularly Aboriginal and Torres Strait Islander children. While in the NT, Christine also oversaw extensive changes to the management of immunisation data to improve the quality of ACIR data for NT children. Under Christine's leadership, immunisation coverage for 12 month old children in the NT improved from 75% to over 90%.
_________________________________________________________________________________________
|
|
Prof Chris Baggoley
Professor Chris Baggoley is the Chief Medical Officer of the Department of Health and Ageing. Professor Chris Baggoley was appointed the Australian Government's Chief Medical Officer on 29 August 2011. He is responsible for a range of professional health issues, including health and medical research, public health, medical workforce, quality of care and evidence based medicine. Professor Baggoley represents the Department of Health and Ageing in key national health committees and medical organisations and has direct responsibility for the Department of Health and Ageing's Office of Health Protection. Prior to his appointment as the Chief Medical Officer he was the Chief Executive of the Australian Commission on Safety and Quality in Health Care, a body whose role is to lead and coordinate the improvements of safety and quality of health care in Australia. He was appointed to that role in December 2007. Chris is a member of the World Health Organization High 5's Project Steering Group and is a member of the Clinical, Technical and Ethical Principal Committee of the Australian Health Ministers' Advisory Council. He also chairs the National Intensive Care Registry Steering Committee and is a member of the Health Care Committee of the National Health and Medical Research Council. Chris is a Professorial Fellow of the School of Medicine, Faculty of Health Sciences, Flinders University of South Australia (FUSA). Prior to his appointment as Chief Executive of the Australian Commission on Safety and Quality in Health Care, Chris was Chief Medical Officer and Executive Director of Public Health and Clinical Coordination in the South Australian Department of Health. His other medical positions were Professor/Director of Emergency Medicine at the University of Adelaide/Royal Adelaide Hospital and Director of Emergency Medicine at Flinders Medical Centre in Adelaide.
Chris' other key roles in health have been as Censor-In-Chief and President of the Australasian College of Emergency Medicine, Chair of the Committee of Presidents of Medical Colleges and Chair of the Board of the National Institute of Clinical Studies. Apart from his university degrees in medicine from the Flinders University of South Australia, he holds an Honours degree in Veterinary Science from Melbourne University and a degree in Social Administration, also from FUSA. His awards include the Order of the International Federation for Emergency Medicine.
_________________________________________________________________________________________
|
|
Dr Tom Snelling
Tom is a paediatric infectious diseases physician at the Sydney Children's Hospital and NHMRC Frank Fenner Early Career Research Fellow at the National Centre for Immunisation Research and Surveillance. He completed his clinical training in Adelaide, Darwin, and Sydney. He is interested in the epidemiology of communicable diseases and in particular quantifying population-level vaccine effects. He undertook a PhD through Charles Darwin University at the Menzies School of Health Research in Darwin, investigating the impact of rotavirus vaccination in the Northern Territory.
_________________________________________________________________________________________
|
|
Prof Michael Good
Professor Michael Good is a NHMRC Australia Fellow at Griffith University, the past Director of the Queensland Institute of Medical Research, a past President of the Association of Australian Medical Research Institutes, and a past Director of the Cooperative Research Centre for Vaccine Technology. In 2006 he was appointed as Chair of the National Health and Medical Research Council of Australia. In 2008 he was a Steering Committee member and Co-Chair of the "long-term national health strategy" of the 2020 Summit. Also in 2008 he was awarded an Officer of the Order of Australia (AO) for service to medical research and contributions to education. In 2009 he won the Australian Museum CSIRO Eureka Prize for Leadership in Science. In 2010 he was named a "Queensland Great" by the Queensland Premier. He graduated MD PhD DSc from the University of Queensland and the Walter and Eliza Hall Institute of Medical Research in Melbourne. He undertook postdoctoral training at the National Institutes of Health in Bethesda, Maryland before returning to Australia in 1988. His interests are in the field of immunity and immunopathogenesis to malaria and group A streptococcus/rheumatic fever, with particular relevance to the development of vaccines. His team is currently testing new vaccines to prevent malaria and rheumatic heart disease, the latter of which is highly prevalent with our Indigenous population
_________________________________________________________________________________________
|
|
A/Prof Kristine Macartney
A/Prof Kristine Macartney is a paediatrician specialising in infectious diseases. She is a medical graduate of the University of New South Wales and undertook her specialty training in Sydney and in the United States at the Children's Hospital of Philadelphia. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She was a founding member of the Vaccine Education Center at the Children's Hospital of Philadelphia, and is currently Deputy Director of Government Programs at the National Centre for Immunisation Research & Surveillance (NCIRS), a paediatric infectious diseases consultant at The Children's Hospital at Westmead, and an Associate Professor in the Discipline of Paediatrics and Child Health, University of Sydney. Her research interests include translation of evidence into policy and practice, vaccine safety, and most other areas of vaccine preventable diseases research, particularly in relation to rotavirus, varicella zoster virus and influenza. She was a co-editor of the Australian Immunisation Handbook (9th Edition, 2008) and has authored many peer-reviewed publications. She is a member of the Advisory Committee on the Safety of Medicines (ACSOM) of the TGA.
______________________________________________________________________________________________________
|
|
Dr Julia Brotherton
Julia Brotherton is a public health physician and Medical Director of Australia's National HPV Vaccination Program Register. She is a medical graduate from the University of Newcastle, NSW, and has a Masters degree in Public Health from the University of Sydney. She completed her speciality training in Public Health Medicine through the NSW Public Health Officers Training Program, and obtained her Fellowship in Public Health Medicine in 2003. For the past eight years Julia has been involved in research and policy development informing the implementation and evaluation of HPV vaccination programs in Australia. Whilst working as a senior research fellow at the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), Julia served as a member of, and technical writer for, the HPV Working Party of the Australian Technical Advisory Group on Immunisation. She is a current member of the Working Party, a member of the HPV Surveillance Working Party of the Communicable Diseases Network Australia and took part in the WHO HPV Monitoring and Surveillance working group in 2009. She has over 60 publications to date.
_________________________________________________________________________________________ |
|
A/Prof Helen Marshall
A/Professor Helen Marshall is the Medical Director of VIRTU, the Vaccinology and Immunology Research Trials Unit, at the Women's and Children's Hospital and Associate Professor in Vaccinology in the School of Paediatrics and Reproductive Health at the University of Adelaide. A/Professor Marshall is a medical graduate of the University of Adelaide who has completed a Master in Public Health degree (University of Adelaide) and the Advanced Vaccinology Course at the Pasteur Merieux Institute, France. She was recently awarded a Doctorate of Medicine from the University of Adelaide, a NHMRC Career Development Fellowship and the South Australia Science Award for Excellence in Research for the Public Good. A/Professor Marshall's research program includes clinical trials in investigational vaccines, epidemiology and public health. A/Professor Marshall has received NHMRC funding for influenza and pertussis vaccine research. Her main interests include meningococcal, Human Papillomavirus and pertussis infections and their prevention by immunisation. A/Professor Marshall has been an investigator on > 40 clinical trials of investigational and licensed vaccines. She has presented her research at many national and international public health, immunisation and infectious disease meetings and published extensively in international peer-reviewed journals.
_____________________________________________________________________________________________________ |
|
Dr Julie Leask
Julie Leask is a Postdoctoral Research Fellow at the School of Public Health, University of Sydney and Senior Research Fellow at the National Centre for Immunisation Research & Surveillance. She has a background in nursing and midwifery with a Master of Public Health (1998) and PhD (2003) from the University of Sydney. Julie leads a team of postgraduates examining determinants of vaccine uptake and improving vaccine risk communication. She has advised governments in Australia, the US and New Zealand, the Decade of Vaccines Collaboration, the US Institute of Medicine, the Council of NHMRC and the Australian Academy of Science. Julie is a member of an international think tank on Motivators of Trust In Vaccination (MOTIV) and a Chief Investigator with the NHMRC Centre of Research Excellence: Immunisation in Understudied and Special Risk Populations.
_________________________________________________________________________________________
|
|
Prof Peter McIntyre
Peter McIntyre is Director of the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), and a Senior Staff Specialist in Infectious Diseases at the Children's Hospital at Westmead. His major interests are in the epidemiology of vaccine preventable diseases, particularly invasive Haemophilus influenzae type b (Hib), pneumococcal disease and pertussis. In Australia, he is a member of the Australian Technical Advisory Group on Immunisation (ATAGI), the Communicable Diseases Network of Australia (CDNA), and the National Immunisation Committee (NIC). Internationally, he is a member of Working Groups for the WHO Strategic Advisory Group of Experts on Pertussis and Pneumococcal vaccines and an invited speaker at international meetings on pertussis and neonatal immunisation. Peter McIntyre is a reviewer for over 10 National and International Journals and the author of over 150 papers and book chapters.
______________________________________________________________________________________________________ |
|
Dr Paul Effler
Paul Effler received a Doctorate in Medicine from the University of California and a Master of Public Health from the University of Hawaii. Upon completing a residency in Public Health Medicine, Dr. Effler served as an Officer in the Epidemic Intelligence Service at the U.S. Centers for Disease Control; he subsequently worked as a consultant to the United Nations High Commissioner for Refugees in Africa and the World Health Organization in Asia. In 1994 he became the State Epidemiologist for Hawaii, a post he held until moving to Australia in 2008. As the State Epidemiologist, Dr Effler directed the public health response to outbreaks of SARS, dengue fever, measles, and rubella and oversaw Hawaii's statewide immunisation program. In 2008 the Hawaii immunisation team won recognition the National Influenza Vaccine Summit for implementing the largest school-based influenza vaccination program in US history - a program that continues today. Dr. Effler is an Associate Editor for the Emerging Infectious Diseases journal and the father of two fully vaccinated children.
___________________________________________________________________________________________
|
|
A/Prof Ross Andrews
Ross Andrews is an epidemiologist with Menzies School of Health Research in Darwin and a collaborator with the NHMRC Centre for Research Excellence in Pneumococcal Vaccinology. Ross is coordinating author of the Cochrane Review of Pneumococcal Vaccines in adults. Ross is a member of Australia's peak ministerial advisory committee on immunisation issues, the Australian Technical Advisory Group on Immunisation (ATAGI), and led the only maternal vaccine trial in the world that has been designed to assess impact against ear disease. He also has major research interests in group A streptococcal infections.
________________________________________________________________________________________________________
|
|
A/Prof Stephen Lambert
Associate Professor Stephen Lambert is a public health physician with a research interest in the epidemiology of vaccine preventable and other communicable diseases. He is an NHMRC early career research Fellow based at the Queensland Children's Medical Research Institute working on a community-based birth cohort study of respiratory and gastrointestinal viral infections in the first two years of life. He also works in the Queensland Health Immunisation Program supporting analysis and research around the impact of vaccines.
________________________________________________________________________________________________________
|
|
Dr Robert Menzies
Rob Menzies is an epidemiologist. He leads the NCIRS surveillance unit, which covers surveillance of vaccine preventable disease, vaccination coverage and adverse events, as well as immunisation in Aboriginal and Torres Strait Islander people. He has particular interests in expanding the use of large administrative datasets and facilitating the use of vaccines in disadvantaged communities. He has worked in several developing countries, and his PhD was conducted at NCIRS, on the epidemiologic analysis of routinely collected data on Indigenous people. He has a conjoint Senior Lecturer appointment at the Sydney Medical School, University of Sydney.
________________________________________________________________________________________________________ |
|
Dr Andrew Steer
Dr Steer is a paediatrician and paediatric infectious diseases physician at the Royal Children's Hospital. He is a Senior Research Fellow at the Centre for International Child Health, and in 2011 was awarded a NHMRC/NHF post-doctoral fellowship. Between 2005-2007, he undertook a US NIH funded project investigating the epidemiology of group A streptococcal disease and rheumatic heart disease in Fiji, for which he was awarded a PhD from the University of Melbourne in 2009, and for which he received a 2010 Dean's Award for Excellence in a PhD Thesis and 2011 Victorian Premier's Award . His interests centre on the control of group A streptococcal disease in developing countries, with specific interests in public health efforts at controlling rheumatic heart disease, impetigo and scabies; understanding the pathogenesis of acute rheumatic fever; and developing a global group A streptococcal vaccine.
________________________________________________________________________________________________________
|
 |
Prof Diana Lennon
Dr Diana Lennon is Professor of Population Health of Children and Youth and Paediatrician in Infectious Diseases at Starship Hospital Auckland. Her research interests are avoidable infectious diseases. She has spear headed Rheumatic Fever and meningococcal disease control and has ongoing research in osteomyelitis, pneumonia and skin sepsis and other areas.
|
|
|
